Pediatric oncology research lab of the Johns Hopkins School of Medicine studying cellular immunotherapy

Joined May 2021
Deeply honored to be selected among many talented @hopkinskimmel postdocs to present my research work in the C3PO Johns Hopkins Postdoc Lecture Series. So grateful for the support of @BonifantLab the past 3 years! #CAR_NKs #AML #JohnsHopkins #TheLastDance
2
2
33
Very excited to see our latest work on COVID-19 therapeutics with @BonifantLab published in @FrontImmunol. Here we describe the use of the novel BananaLectin-CAR engineered NK cells for the treatment of SARS-CoV-2 infection. #COVID19 #CAR_NK #BananaLectin frontiersin.org/article/10.3…
1
3
7
Thrilled to see our new work with @BonifantLab at @hopkinskimmel published in @jitcancer !
New #JITC article: Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities bit.ly/323FmsI @ChristodoulouMD
2
2
1
24
Congrats Ilias! Awesome work!
1
1
1
Bonifant Lab retweeted
Congrats Ilias; great work :)!
1
1
1
Excited to share our work with @BonifantLab! Here we describe the design and testing of NK cell-specific CARs targeting the CD123 antigen on AML cells. We also enhanced the anti-AML activation of CAR-NK cells with secretory IL15 and explored their in vivo therapeutic potential.
Engineering CAR-NK cells to secrete IL15 sustains their anti-AML functionality, but is associated with systemic toxicities biorxiv.org/cgi/content/shor… #bioRxiv
2
2
12
Bonifant Lab retweeted
Well done Kates! Banana (lectin)-powered CAR T-cells will defeat solid tumors. Malcolm Brenner @CAGTHouston collab with @BonifantLab and U Michigan
IOYIF@IOYIForum1 Aug 2021
The #IOYIF21 1st place winner in the PhD Postdoc category is Dr. Mary Kathryn McKenna for her work using banana lectin-powered T-cells to augment targeted therapies in solid tumors. Congratulations, Dr. McKenna! @bcmhouston @CAGTHouston
1
2
11
Replying to @HopkinsBio
@HopkinsBio major Wesley Ravich's passion is to work in pediatric oncology and he has done just that since arriving at Hopkins. His work in the @BonifantLab is focused on the field of cellular immunotherapy, which is poised to revolutionize leukemia therapy. #CancerResearch

1
2